Lataa...
The Quinoxaline Antitumor Agent (R+)XK469 Inhibits Neuroblastoma Tumor Growth
The quinoxaline antitumor agent (R+)XK469 mediates its effects by topoisomerase IIB inhibition. This report describes a 14 year-old with relapsed neuroblastoma who experienced disease stabilization for 14 months while receiving (R+)XK469 monotherapy. Due to this favorable response, laboratory studie...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116189/ https://ncbi.nlm.nih.gov/pubmed/20860039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22639 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|